These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18497248)

  • 41. Preventing nephropathy induced by contrast medium.
    Gross JL; Friedman R; Silveiro SP
    N Engl J Med; 2006 Apr; 354(17):1853-5; author reply 1853-5. PubMed ID: 16641408
    [No Abstract]   [Full Text] [Related]  

  • 42. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diabetes mellitus and heart failure: epidemiology and therapy].
    Pfister R; Erdmann E
    Herz; 2008 Apr; 33(3):178-83. PubMed ID: 18568311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride.
    Huo T; Cai S; Lu X; Sha Y; Yu M; Li F
    J Pharm Biomed Anal; 2009 May; 49(4):976-82. PubMed ID: 19249171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Perioperative management of chronic treatment and medical devices. Endocrine pathology].
    Raucoules M; Asehnoune K; Carles M; Deleuze A;
    Ann Fr Anesth Reanim; 2011 Feb; 30(2):195-9. PubMed ID: 21316908
    [No Abstract]   [Full Text] [Related]  

  • 46. Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
    Goodarzi MO; Azziz R
    Am J Med; 2008 Aug; 121(8):e9; author reply e11. PubMed ID: 18691471
    [No Abstract]   [Full Text] [Related]  

  • 47. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute renal failure from contrast medium: beware patients taking metformin..
    Sayer JA
    BMJ; 2006 Sep; 333(7569):653. PubMed ID: 16990332
    [No Abstract]   [Full Text] [Related]  

  • 49. [Metformin role in the treatment of type 2 diabetes in 2008].
    Spada A; Philippe J
    Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin-induced pancreatitis: A possible adverse drug effect during acute renal failure.
    Fimognari FL; Corsonello A; Pastorell R; Antonelli-Incalzi R
    Diabetes Care; 2006 May; 29(5):1183. PubMed ID: 16644670
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of Diabetes in People With Heart Failure.
    ; Connelly KA; Gilbert RE; Liu P
    Can J Diabetes; 2018 Apr; 42 Suppl 1():S196-S200. PubMed ID: 29650096
    [No Abstract]   [Full Text] [Related]  

  • 52. Addressing insulin resistance in Type 1 diabetes.
    Pang TT; Narendran P
    Diabet Med; 2008 Sep; 25(9):1015-24. PubMed ID: 19183305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus.
    Mazziotti G; Bossoni S; Orini S; Salimbeni P; Gazzaruso C; Solerte BS; Vescovi P; Romanelli G; Giustina A
    J Am Geriatr Soc; 2009 Mar; 57(3):562-4. PubMed ID: 19278401
    [No Abstract]   [Full Text] [Related]  

  • 54. A pharmacist's perspective on metformin use and cancer outcomes.
    Ceacareanu AC
    J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081
    [No Abstract]   [Full Text] [Related]  

  • 55. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
    Scherbaum WA
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
    [No Abstract]   [Full Text] [Related]  

  • 56. ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all?
    Martínez-Castelao A; Górriz JL; Ortiz A; Navarro-González JF
    Nefrologia; 2017; 37(6):567-571. PubMed ID: 28669489
    [No Abstract]   [Full Text] [Related]  

  • 57. Does glucose infusion exacerbate metformin-associated lactate acidosis? A case report.
    Brouwers MC; Schaper N; Keeris L
    Diabetes Res Clin Pract; 2009 Jul; 85(1):e1-3. PubMed ID: 19427052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A clinical case of lactic acidosis development in a diabetic patient taking metformin].
    Cezur M; Celmen N; Cetinbas R; Badalov P; Erdemli O
    Anesteziol Reanimatol; 2009; (2):74-6. PubMed ID: 19514447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):234-43. PubMed ID: 19421967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Metformin and intravascular contrast media. National guidelines 2001-03-16].
    Lakartidningen; 2001 Apr; 98(16):1935-6. PubMed ID: 11370412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.